Portfolio Company · Operating Co.
GB

Genetix Biotherapeutics

CurrentHealthcare
Genetix Biotherapeutics
a portfolio company of
The Carlyle Group
Status on record: Current
Investment year: 2025
PE Firm Index

Who owns Genetix Biotherapeutics?

Genetix Biotherapeutics is listed as a current portfolio company of The Carlyle Group on The Carlyle Group's own portfolio page. The Carlyle Group has owned Genetix Biotherapeutics since 2025, per The Carlyle Group's portfolio page.

Checking another company? Use the free who owns this company lookup.

Company Snapshot

Genetix Biotherapeutics is a Healthcare company. Its owner on record, The Carlyle Group, is a leveraged buyouts firm founded in 1987, headquartered in Washington, D.C., USA, with $441 billion under management. The Carlyle Group lists 257 companies in the index, 41 of them in Healthcare.

Parent PE firmThe Carlyle Group
Ownership statusCurrent
WebsiteNot on record

About the owner

Headquarters
Washington, D.C., USA
Founded
1987
AUM
$441 billion
Strategy
Leveraged Buyouts, Growth Capital, Structured Credit, Real Estate, Secondary Investments, Co-investments
Sectors
Private Equity, Real Assets, Private Credit
Companies in the index
257

The Carlyle Group is an American multinational private equity, alternative asset management, and financial services firm.

Read the The Carlyle Group profile

Questions about Genetix Biotherapeutics

Who owns Genetix Biotherapeutics?

Genetix Biotherapeutics is listed as a current portfolio company of The Carlyle Group on The Carlyle Group's own portfolio page. The Carlyle Group has owned Genetix Biotherapeutics since 2025, per The Carlyle Group's portfolio page.

What sector is Genetix Biotherapeutics in?

Genetix Biotherapeutics is in Healthcare. Classified from the owner's portfolio label.

Where is The Carlyle Group headquartered?

The Carlyle Group is headquartered in Washington, D.C., USA.

What else does The Carlyle Group own in Healthcare?

The Carlyle Group lists 40 other Healthcare companies in the index, including Abacus Pharmaceuticals, Abbisko, Acufocus, Inc., Adicon Holdings Limited and Ambio Holdings, Inc..

Sources

This profile is based on publicly available information and may be incomplete or outdated. PE Firm Index is not affiliated with Genetix Biotherapeutics and does not provide investment advice.

Other portfolio companies of The Carlyle Group

6 of 256 shown

See the full The Carlyle Group portfolio.

Other Healthcare companies held by The Carlyle Group

Other Healthcare portfolio companies

Browse PE-backed companies.